Question

please type the answer up no hand written notes. thank you

Critical Thinking Questions for Submissions:

1. When is the use enteral nutrition contraindicated? What are the alternative therapies, the healthcare provider might use instead?
2. Before administering intravenous potassium, what assessments need to be made?
3. List the side effects of parenteral feedings that need to be reported to the prescribing practitioner?

Answer 1

a) contraindication for enteral nutrition:

Although the enteral route should always be the first option, there may be occasions when it is contraindicated. These include

• absence of intestinal function due to failure, severe inflammation or, in some instances, post operative stasis

• complete intestinal obstruction

• inability to access the gut e.g. severe burns, multiple trauma

• high loss intestinal fistulaea

• relative contraindication to tube feeding is also increased likelihood of opportunistic infection e.g. maxillo-facial surgery or oncology treatments

• ethical considerations e.g. terminal care.

• The health alternative therapies, the healthcare provider might use instead parentral nutrition

  b)Parenteral nutrition, or intravenous feeding, is a method of getting nutrition into your body through your veins. Depending on which vein is used, this procedure is often referred to as either total parenteral nutrition (TPN) or peripheral parenteral nutrition (PPN).

• This form of nutrition is used to help people who can’t or shouldn’t get their core nutrients from food. It’s often used for people with:

• Crohn’s disease
• cancer

• It also can help people with conditions that result from low blood flow to their bowels

• short bowel syndrome
• ischemic bowel disease
• C)ASSESSMENT -Before administration through IV the nurse should monitor the conduction of heart and nerve impulses and brain and skeletal muscles and also the renal function and acid base balance
• Nurse should be assessed while administering the IV potassium IV fluid maintenance should be there
• While administering the drug potassium ECG monitoring is compulsory while intravenous and potassium dosages is up to advocated the patient should be no more than the 20 mEq/hour intravenously to avoid the potential effects on the cardiac conduction system
• d)The side effects mainly are reported to the physician if there is any changes in the heartbeat and the difficulty in breathing we need to report to the physician and also the convulsions which has been noticed we have to report to the physician
• Thank you
• Please rate the answer